The OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
Moderna reported better-than-expected 1Q24 revenue of $167 million and its pipeline looks promising. Read my earnings ...
Moderna Chief Executive Officer Stéphane Bancel talks about how the biotech giant is cutting costs and developing new vaccines. The drugmaker expects to have its vaccine for respiratory syncytial ...
The U.S. Food and Drug Administration on Wednesday approved the expanded use of Bristol Myers Squibb's cancer cell therapy Breyanzi to include the treatment of adults with a type of blood cancer that ...
This article discusses Donald Trump convicted on 34 charges of falsifying business records, the upcoming PCE data, Boeing's ...
Economic data: China releases purchasing managers’ index data for May, Hong Kong publishes April retail sales and Japan ...
Real-time index price for KBW Capital Markets Index (KSX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
UK house prices returned to growth in May on the back of strengthening consumer confidence, according to data published on Friday. The lender Nationwide said house prices increased by 0.4 per cent ...
A man with a suspended license joined his court Zoom call while driving, astonishing the judge and his legal team.
Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of the 30 most popular stocks among hedge funds at the ...